NRx Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
NRx Pharmaceuticals, Inc.‘s stocks are currently a part of 18 hedge funds’ portfolios, which represents 1.09% of the total amount of its stocks outstanding. This makes up a total of 716.32K shares of NRx Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -76.87% or -2.38M shares fewer. As for the holding position changes, 33.33% (6) of current hedge fund investors increased the number of shares held, 16.67% (3) of current holders sold a part of the shares held, and 16.67% (3) closed the holdings completely. 1 hedge funds are new holders of NRx Pharmaceuticals, Inc. stock in Q1 2023, it is 5.56% of total holders.
Hedge funds holding NRx Pharmaceuticals (Q4 2016 – Q1 2023)
| Q4 2016 | 1 |
|---|---|
| Q1 2017 | 1 |
| Q2 2017 | 0 |
| Q1 2019 | 1 |
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 1 |
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 18 |
| Q3 2021 | 23 |
| Q4 2021 | 38 |
| Q1 2022 | 33 |
| Q2 2022 | 32 |
| Q3 2022 | 25 |
| Q4 2022 | 31 |
| Q1 2023 | 18 |
Hedge funds changes in NRx Pharmaceuticals positions (Q4 2016 – Q1 2023)
| Q4 2016 | 0 | 0 | 0 | 0 | 1 |
|---|---|---|---|---|---|
| Q1 2017 | 0 | 0 | 0 | 0 | 1 |
| Q2 2017 | 0 | 0 | 0 | 1 | -1 |
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 0 | 0 | 0 | 0 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 1 |
| Q2 2020 | 0 | 0 | 0 | 0 | 1 |
| Q3 2020 | 0 | 0 | 0 | 0 | 1 |
| Q4 2020 | 0 | 0 | 0 | 0 | 1 |
| Q1 2021 | 0 | 0 | 0 | 0 | 1 |
| Q2 2021 | 17 | 0 | 0 | 0 | 1 |
| Q3 2021 | 14 | 7 | 1 | 8 | -7 |
| Q4 2021 | 20 | 9 | 6 | 5 | -2 |
| Q1 2022 | 8 | 12 | 8 | 13 | -8 |
| Q2 2022 | 6 | 12 | 6 | 8 | 0 |
| Q3 2022 | 2 | 8 | 6 | 8 | 1 |
| Q4 2022 | 12 | 7 | 6 | 6 | 0 |
| Q1 2023 | 1 | 6 | 3 | 3 | 5 |
Hedge funds changes in NRx Pharmaceuticals stock options (Q4 2016 – Q1 2023)
| Q4 2016 | 0 | 0 |
|---|---|---|
| Q1 2017 | 0 | 0 |
| Q2 2017 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 3,242,000 | 6,647,000 |
| Q4 2021 | 2,925,000 | 3,630,000 |
| Q1 2022 | 1,337,000 | 1,055,000 |
| Q2 2022 | 237,000 | 67,000 |
| Q3 2022 | 274,000 | 53,000 |
| Q4 2022 | 358,221 | 50,728 |
| Q1 2023 | 19,397,000 | 5,339,000 |